Luca Sforzini

Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial

Maria Antonietta Nettis, Giulia Lombardo, Caitlin Hastings et al. · Neuropsychopharmacology · 2021 · 234 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study

Annamaria Cattaneo, Clarissa Ferrari, Lorinda Turner et al. · Translational Psychiatry · 2020 · 114 citations · Full text

Life Sciences, Immunology, Psychiatry +17

Cause or consequence? Understanding the role of cortisol in the increased inflammation observed in depression

Nare Amasi-Hartoonian, Luca Sforzini, Annamaria Cattaneo et al. · Current Opinion in Endocrine and Metabolic Research · 2022 · 64 citations · Full text

Life Sciences, Endocrinology, Psychiatry +17

PET imaging shows no changes in TSPO brain density after IFN-α immune challenge in healthy human volunteers

Maria Antonietta Nettis, Mattia Veronese, Naghmeh Nikkheslat et al. · Translational Psychiatry · 2020 · 53 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Transcriptomic profiles in major depressive disorder: the role of immunometabolic and cell-cycle-related pathways in depression with different levels of inflammation

Luca Sforzini, Moira Marizzoni, Chiara Bottanelli et al. · Molecular Psychiatry · 2024 · 37 citations · Full text

Life Sciences, Immunology, Psychiatry +17